Clinical Translation of Cell Therapies in Stroke (CT2S) Checklist-a pragmatic tool to accelerate development of cell therapy products.

Nagpal A, Milton AG, Koblar SA, Hamilton-Bruce MA

Open source

DOI
10.1186/s13287-021-02147-6
Published
2021 Jan 29
Container
Stem cell research & therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13287-021-02147-6,
  title = {Clinical Translation of Cell Therapies in Stroke (CT2S) Checklist-a pragmatic tool to accelerate development of cell therapy products.},
  author = {Nagpal A and Milton AG and Koblar SA and Hamilton-Bruce MA},
  year = {2021},
  journal = {Stem cell research \& therapy},
  doi = {10.1186/s13287-021-02147-6},
  url = {https://doi.org/10.1186/s13287-021-02147-6}
}

RIS

TY  - JOUR
TI  - Clinical Translation of Cell Therapies in Stroke (CT2S) Checklist-a pragmatic tool to accelerate development of cell therapy products.
AU  - Nagpal A
AU  - Milton AG
AU  - Koblar SA
AU  - Hamilton-Bruce MA
PY  - 2021
JO  - Stem cell research & therapy
DO  - 10.1186/s13287-021-02147-6
UR  - https://doi.org/10.1186/s13287-021-02147-6
ER  - 

APA

A, N., AG, M., SA, K., & MA, H. (2021). Clinical Translation of Cell Therapies in Stroke (CT2S) Checklist-a pragmatic tool to accelerate development of cell therapy products.. Stem cell research & therapy. https://doi.org/10.1186/s13287-021-02147-6

Source records